UroGen Pharma
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $24,565 | $25,204 | $21,848 | $18,781 |
Gross Profit | 22,094 | 22,751 | 19,619 | 17,053 |
EBITDA | -30,665 | -14,680 | -25,576 | -25,389 |
EBIT | -30,971 | -14,946 | -25,839 | -25,740 |
Net Income | -37,512 | -23,673 | -33,403 | -32,286 |
Net Change In Cash | 24,565 | 25,204 | 21,848 | 18,781 |
Free Cash Flow | -13,734 | -27,760 | -23,832 | -31,735 |
Cash | 171,987 | 124,916 | 220,797 | 132,262 |
Basic Shares | 42,876 | 43,100 | 36,821 | 33,379 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $90,398 | $82,713 | $64,357 | $48,042 |
Gross Profit | 81,517 | 73,352 | 56,703 | 42,885 |
EBITDA | -110,335 | -63,831 | -78,031 | -90,154 |
EBIT | -111,521 | -65,536 | -79,848 | -91,927 |
Net Income | -126,874 | -102,244 | -109,163 | -110,820 |
Net Change In Cash | 90,398 | 82,713 | 64,357 | 48,042 |
Cost of Revenue | 10,635 | -8,504 | ||
Free Cash Flow | -97,061 | -76,570 | -87,813 | -85,644 |
Cash | 171,987 | 95,002 | 55,408 | 44,360 |
Basic Shares | 42,876 | 28,834 | 22,806 | 22,347 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.80 |
2024-09-30 | -$0.55 |
2024-06-30 | -$0.91 |
2024-03-31 | -$0.97 |
